Clincosm LogoSign in Get a demo

Hormone-resistant Prostate Cancer

Showing 26 - 50 of 52
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Baltimore (Dexamethasone,

Terminated
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Jul 11, 2018

Castration Levels of Testosterone, Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma in the Soft Tissue Trial in

Terminated
Has Results
  • Castration Levels of Testosterone
  • +5 more
  • San Francisco, California
    University of California, San Francisco
May 29, 2018

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Omaha (lenalidomide,

Terminated
Has Results
  • Adenocarcinoma of the Prostate
  • +2 more
  • Omaha, Nebraska
    University of Nebraska Medical Center
May 7, 2018

Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Duarte (saracatinib, laboratory biomarker analysis)

Completed
Has Results
  • Hormone-resistant Prostate Cancer
  • Recurrent Prostate Cancer
  • Duarte, California
    City of Hope
Mar 21, 2018

Castration Levels of Testosterone, Hormone-Resistant Prostate Cancer, Microsatellite Instability Trial in Seattle (Durvalumab,

Withdrawn
  • Castration Levels of Testosterone
  • +2 more
  • Durvalumab
  • Laboratory Biomarker Analysis
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 12, 2018

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Philadelphia (Alisertib,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Nov 8, 2017

Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (drug, other,

Terminated
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Jacksonville, Florida
  • +13 more
Aug 21, 2017

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Los Angeles (orteronel,

Terminated
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Jul 31, 2017

Prostate Cancer, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Los Angeles (laboratory biomarker

Completed
  • Prostate Cancer
  • +3 more
  • laboratory biomarker analysis
  • +2 more
  • Los Angeles, California
    University of Southern California
Jul 5, 2017

Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Los Angeles (abiraterone

Unknown status
  • Hormone-resistant Prostate Cancer
  • +2 more
  • abiraterone acetate
  • +2 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Jul 5, 2017

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Stanford

Terminated
  • Hormone-Resistant Prostate Cancer
  • +2 more
  • Contrast-enhanced Magnetic Resonance Imaging
  • +4 more
  • Stanford, California
    Stanford University, School of Medicine
May 24, 2017

Hormone-Resistant Prostate Cancer, Recurrent Prostate Carcinoma Trial in Canada (Bicalutamide, Laboratory Biomarker Analysis,

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • Recurrent Prostate Carcinoma
  • Vancouver, British Columbia, Canada
  • +5 more
Apr 17, 2017

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Portland (drug, dietary

Terminated
  • Adenocarcinoma of the Prostate
  • +3 more
  • abiraterone acetate
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Apr 26, 2017

Estrogen Receptor Negative, Head and Neck Squamous Cell Carcinoma, HER2/Neu Negative Trial (Laboratory Biomarker Analysis,

Withdrawn
  • Estrogen Receptor Negative
  • +22 more
  • Laboratory Biomarker Analysis
  • +2 more
  • (no location specified)
Apr 20, 2017

CTCs and ctDNA in Blood and Plasma Samples From Metastatic

Terminated
  • Hormone-Resistant Prostate Cancer
  • Metastatic Prostate Carcinoma
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Apr 13, 2017

Prostate Cancer, Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer Trial in Scottsdale (bicalutamide,

Completed
  • Prostate Cancer
  • +3 more
  • Scottsdale, Arizona
    Mayo Clinic In Arizona
Mar 21, 2017

Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Buffalo (biological, other, drug)

Completed
  • Anaplastic Astrocytoma
  • +64 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2016

Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Seattle (radiation, procedure,

Withdrawn
  • Hormone-resistant Prostate Cancer
  • +2 more
  • carbon-11 acetate
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Aug 29, 2016

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Buffalo (other,

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 19, 2016

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Recurrent Prostate Carcinoma Trial in United States

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Fluorine F 18 Sodium Fluoride
  • Boston, Massachusetts
  • +3 more
Jun 22, 2015

Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in United States (saracatinib,

Terminated
Has Results
  • Hormone-resistant Prostate Cancer
  • +2 more
  • Chicago, Illinois
  • +14 more
Mar 18, 2015

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Cleveland (linsitinib,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • Cleveland, Ohio
  • +1 more
Mar 2, 2015

Diarrhea, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Los Angeles (cabazitaxel, prednisone, octreotide

Terminated
  • Diarrhea
  • +7 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Nov 21, 2014

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in New Haven, Chicago (drug,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • New Haven, Connecticut
  • +1 more
Apr 21, 2014

Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Los Angeles (drug, other, genetic)

Completed
Has Results
  • Hormone-resistant Prostate Cancer
  • Recurrent Prostate Cancer
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Feb 5, 2014